What Vital Cancer Drugs Are Facing The English Axe?

Thousands of cancer patients in the UK could lose access to vital medicines unless drastic changes are made. Currently, 25 drugs, deemed too expensive for the NHS (but available through the Cancer Drugs Fund) could be axed under new plans, including all six breast cancer drugs prescribed to thousands in three years. Read more here. (Source: MailOnline, 11/17/14).

You might also be interested in:

Report: NHS Failing to Treat Common Causes of Death June 26, 2018
Study: ICER Value Assessments Could Leave Medicare Part B… June 2, 2018
Top 5 Signs You Are Ready for an Online Master’s Degree in… June 12, 2018
Study: Expensive Brand Drugs Driving up Prices November 18, 2018
U.K. Ruling Could Save NHS ‘Hundreds of Millions’ Annually September 22, 2018
23andMe Gets OK from FDA to Report Breast Cancer Risk April 20, 2018
Patients in China Turn to Drastic Measures to Get Much-Needed Care November 26, 2018